White Anne E.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to White Anne E.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LLY | EVP & Pres, Lilly Neuroscience | Award / Grant | 6,829 | $868.88 | $5,933,469 | Feb 10, 2025 |
| LLY | EVP & Pres, Lilly Neuroscience | Option Exercise | 3,269 | — | — | Feb 1, 2025 |
| LLY | EVP & Pres, Lilly Neuroscience | Award / Grant | 5,363 | $737.26 | $3,953,925 | Feb 12, 2024 |
| LLY | EVP & Pres, Lilly Neuroscience | Tax Withholding | 1,844 | $645.61 | $1,190,505 | Feb 1, 2024 |
| LLY | EVP & Pres, Lilly Neuroscience | Sale | 2,500 | $346.47 | $866,175 | Feb 10, 2023 |
| LLY | EVP & Pres, Lilly Neuroscience | Option Exercise | 7,264 | — | — | Feb 1, 2023 |
| LLY | SVP & Pres-Lilly Neuroscience | Award / Grant | 11,348 | $243.27 | $2,760,628 | Feb 9, 2022 |
| LLY | SVP & Pres-Lilly Neuroscience | Tax Withholding | 4,204 | $245.39 | $1,031,620 | Feb 1, 2022 |
| LLY | SVP & Pres-Lilly Oncology | Award / Grant | 4,718 | $205.77 | $970,823 | Feb 8, 2021 |
| LLY | SVP & Pres-Lilly Oncology | Award / Grant | 7,079 | $144.25 | $1,021,146 | Feb 11, 2020 |
| LLY | SVP & Pres-Lilly Oncology | Purchase | 1,000 | $108.84 | $108,840 | Oct 25, 2019 |
| LLY | SVP & Pres-Lilly Oncology | Award / Grant | 7,246 | $120.17 | $870,752 | Feb 4, 2019 |
| LLY | SVP & Pres-Lilly Oncology | Tax Withholding | 3,306 | $118.64 | $392,224 | Dec 2, 2018 |